Cargando…

Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells

Increased angiogenic activity has been demonstrated in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), but the mechanism was unclear. To study the role of HCV core protein, we used tube formation and Matrigel plug assays to assess the proangiogenic activity of an HCC cell line, HuH7,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Yu-Yun, Hsieh, Min-Shu, Wang, Han-Yu, Li, Yong-Shi, Lin, Hang, Hsu, Hung-Wei, Huang, Chung-Yi, Hsu, Chih-Hung, Cheng, Ann-Lii
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689717/ https://www.ncbi.nlm.nih.gov/pubmed/29156827 http://dx.doi.org/10.18632/oncotarget.21407

Ejemplares similares

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
por: Hsu, Chih-Hung, et al.
Publicado: (2014)

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2021)

Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
por: Chen, Bang-Bin, et al.
Publicado: (2021)

Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
por: Lin, Zhong-Zhe, et al.
Publicado: (2013)

Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
por: Chen, Bang-Bin, et al.
Publicado: (2021)

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy
por: Shen, Ying-Chun, et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma
por: Tsai, Wei-Lun, et al.
Publicado: (2014)

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2021)

Increased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus Infection
por: Tseng, Chun-Hung, et al.
Publicado: (2015)

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma
por: Shen, Ying-Chun, et al.
Publicado: (2021)

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
por: Hsu, Che-Yu, et al.
Publicado: (2019)

Hepatic resection for hepatocellular carcinoma in the octogenarian: is it justified?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Liver regeneration accelerates hepatitis B virus‐related tumorigenesis of hepatocellular carcinoma
por: Teng, Chiao‐Fang, et al.
Publicado: (2018)

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
por: Liao, Yen-Hsiang, et al.
Publicado: (2020)

Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma
por: Lee, Jan-Mou, et al.
Publicado: (2022)

Hepatitis C virus core protein: Not just a nucleocapsid building block, but an immunity and inflammation modulator
por: Mani, Hemalatha, et al.
Publicado: (2021)

H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
por: Shen, Yu-Chuan, et al.
Publicado: (2022)

Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection
por: Huang, Cih-En, et al.
Publicado: (2022)

Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells
por: Chen, Yun-Ju, et al.
Publicado: (2013)

Effects of sex and generation on hepatitis B viral load in families with hepatocellular carcinoma
por: Hsieh, Ai-Ru, et al.
Publicado: (2017)

Primary hepatic carcinoid tumor: a case report and review of the literature
por: Lin, Chih-Wen, et al.
Publicado: (2009)

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer
por: Guo, Jhe‐Cyuan, et al.
Publicado: (2023)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
por: Lin, Chih-Wen, et al.
Publicado: (2020)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
por: Huang, Wei-Chien, et al.
Publicado: (2013)

Hepatocellular carcinoma in hemodialysis patients
por: Lee, Chern-Horng, et al.
Publicado: (2017)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
por: Lo, Yuan-Chen, et al.
Publicado: (2019)

Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
por: Hsu, Axel, et al.
Publicado: (2011)

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)

Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2022)

In vivo properties of the proangiogenic peptide QK
por: Santulli, Gaetano, et al.
Publicado: (2009)

The Levels of Circulating Proangiogenic Factors in Migraineurs
por: Michalak, Slawomir, et al.
Publicado: (2017)

Hypoxia and proangiogenic proteins in human ameloblastoma
por: de Mendonça, Raíssa Pinheiro, et al.
Publicado: (2020)

Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation
por: Chang, Ming-Ling, et al.
Publicado: (2009)

Asunaprevir Evokes Hepatocytes Innate Immunity to Restrict the Replication of Hepatitis C and Dengue Virus
por: Tsai, Wei-Lun, et al.
Publicado: (2017)

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma
por: Chiu, Shih-Hsin, et al.
Publicado: (2014)

Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C
por: Lin, Sheng Feng, et al.
Publicado: (2020)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Liang, Hsin-Rou, et al.
Publicado: (2021)

Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients
por: Chang, Chia-Ming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t985tiafgjlaij90rhf501k7rb